Rockefeller Capital Management L.P. Tg Therapeutics, Inc. Transaction History
Rockefeller Capital Management L.P.
- $42.4 Billion
- Q2 2025
A detailed history of Rockefeller Capital Management L.P. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Rockefeller Capital Management L.P. holds 11,676 shares of TGTX stock, worth $394,181. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,676
Previous 11,676
-0.0%
Holding current value
$394,181
Previous $420,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding TGTX
# of Institutions
406Shares Held
92.4MCall Options Held
2.28MPut Options Held
1.78M-
Vanguard Group Inc Valley Forge, PA15.8MShares$534 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$384 Million0.0% of portfolio
-
State Street Corp Boston, MA7.62MShares$257 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$118 Million0.01% of portfolio
-
Clearbridge Investments, LLC New York, NY3.05MShares$103 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.9B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...